| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/29/1999 | WO1999037777A2 Differentiation-associated sequences and methods of use therefor |
| 07/29/1999 | WO1999037774A2 Differentiation-associated sequences and methods of use therefor |
| 07/29/1999 | WO1999037760A1 Inhibition of cytokine production |
| 07/29/1999 | WO1999037755A2 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 07/29/1999 | WO1999037751A1 Purified populations of stem cells |
| 07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | WO1999037331A1 Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein |
| 07/29/1999 | WO1999037325A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 07/29/1999 | WO1999037322A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | WO1999037320A1 Methods and compositions for enhancing cognitive function using morphogenic proteins |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999031227A3 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | CA2320624A1 Mutants of il-16, processes for their production, and their use |
| 07/29/1999 | CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318382A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2317839A1 Inhibition of cytokine production |
| 07/29/1999 | CA2314246A1 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 07/29/1999 | CA2311729A1 Purified populations of stem cells |
| 07/28/1999 | EP0931830A2 Cytopathic viruses for therapy and phophylaxis of neoplasia |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931157A1 Retroviral vectors |
| 07/28/1999 | EP0931156A2 Gene expression and delivery systems and uses |
| 07/28/1999 | EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0930896A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors |
| 07/28/1999 | EP0930894A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 07/28/1999 | EP0930892A1 Cytokine enhanced immunotherapy for brain tumors |
| 07/28/1999 | EP0930890A1 USE OF FasL OR FasL TRANSFECTED CD4?+ /FasL?- /TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES |
| 07/28/1999 | EP0743958A4 Non-viral vector |
| 07/28/1999 | EP0565604B1 Catheter for drug delivery system |
| 07/28/1999 | CN1224428A Cellular injury response element and uses thereof |
| 07/27/1999 | US5929226 Three or more but not all nucleotides are connected with methylphosphonothioate linkages where sulfur is not bridging atom; increased resistance to nucleases, increased duplex stability |
| 07/27/1999 | US5929225 Human gene homologous to bacterial gene controlling sensitivity to methyl methane sulfonate; anticarcinogenic agents; for repairing alkylated nucleic acids; for treating cell death; antagonists to prevent tumor nucleic acid repair |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5929044 Composition comprising a protein solder, a bioactive compound, and a vehicle for delivering said bioactive compound into a target cell having a genome, wherein said vehicle is a virus or a liposome |
| 07/27/1999 | US5929043 Inhibiting copying of dna at target sequence in viable cell by introducing into said cell a pair of nucleoprotein filaments, where the filaments each comprise a ssdna strand coated with a recombinase, forming double d-loop |
| 07/27/1999 | US5929041 Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5928944 Method of adenoviral-medicated cell transfection |
| 07/27/1999 | US5928943 Embryonal cardiac muscle cells, their preparation and their use |
| 07/27/1999 | US5928940 Morphogen-responsive signal transducer and methods of use thereof |
| 07/27/1999 | US5928924 A isolate polypeptide encoded by genetic engineered hybridized polynucleotide for controlling morphology of cells; antagonist against such polypeptides and their use as a therapeutic to treat cancer |
| 07/27/1999 | US5928920 Amino acid sequence of enzyme which catalyzes addition of threonyl to transfer ribonucleic acid; for bacteristats and bactericides |
| 07/27/1999 | US5928913 Herpes virus amplicon coding for antigen or immunomodulatory protein with replication-deficient helper herpes virus; for gene therapy and vaccines |
| 07/27/1999 | US5928638 Treating stem cells with hydroxyurea, introducing gene into treated cells using retroviral mediated gene transfer |
| 07/22/1999 | WO1999036566A1 Mmsc1 - an mmac1 interacting protein |
| 07/22/1999 | WO1999036562A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | WO1999036560A2 Viral vectors encoding neurofilament light proteins and their use |
| 07/22/1999 | WO1999036559A1 Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use |
| 07/22/1999 | WO1999036558A2 Viral vectors encoding neurofilament heavy proteins and their use |
| 07/22/1999 | WO1999036557A1 Novel promoter elements for persistent gene expression |
| 07/22/1999 | WO1999036553A2 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | WO1999036548A1 Human lymphoid protein tyrosine phosphatases |
| 07/22/1999 | WO1999036545A2 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | WO1999036544A2 Neisseria meningitidis antigens |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036538A1 Enhancement of cardiac chronotropy |
| 07/22/1999 | WO1999036536A2 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system |
| 07/22/1999 | WO1999036533A2 Nucleic acid corresponding to mutation associated with cholestasis syndromes |
| 07/22/1999 | WO1999036530A2 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | WO1999036525A1 Cbfblh12: a gene highly related to bovine ci-kfyi gene for ubiquinone oxireductase complex |
| 07/22/1999 | WO1999036519A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/22/1999 | WO1999036518A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | WO1999036514A1 Methods and compositions for gene delivery |
| 07/22/1999 | WO1999036511A2 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | WO1999036440A2 Expression of fusion proteins |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN |
| 07/22/1999 | WO1999036435A1 CBCAAC01: A RNA POLYMERASE-I SUBUNIT hRPA39 RELATED GENE WHICH IS SIMILAR TO MOUSE RNA POLYMERASE-I 40kD SUBUNIT |
| 07/22/1999 | WO1999036433A2 Materials and methods for treating oncological disease |
| 07/22/1999 | WO1999036103A1 Prevention and treatment of neuropathy by hepatocyte growth factor |
| 07/22/1999 | WO1999036102A1 GENETIC MANIPULATION BY 3' UNTRANSLATED SEQUENCES OF mRNA |
| 07/22/1999 | WO1999036094A2 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen |
| 07/22/1999 | WO1999036090A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | WO1999036089A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | WO1999036082A2 The use of increased neurofilament protein levels as protection and therapy against neurodegeneration with oxidative stress involvement |
| 07/22/1999 | WO1999036079A1 A noncleavable fas ligand |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999028489A3 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 07/22/1999 | WO1999028439A3 Erythrovirus and its applications |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1999025814B1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 07/22/1999 | WO1999025721B1 Detection and treatment of retinal degenerative disease |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | CA2318697A1 Human lymphoid protein tyrosine phosphatases |
| 07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | CA2318663A1 Methods and compositions for gene delivery |